- Home
- Signaling Pathways
- Apoptosis
- Thymidylate Synthase
- Triflurdine (Viroptic)
Triflurdine (Viroptic)
Catalog No.
A8542
Anti-herpesvirus antiviral drug
Featured Products
Trifluridine (also called trifluorothymidine or TFT) is an anti-herpesvirus antiviral drug, used primarily on the eye. It was sold under the trade name, Viroptic, by Glaxo Wellcome, now merged into GlaxoSmithKline. The brand is now owned by Monarch Pharmaceuticals, which is wholly owned by King Pharmaceuticals.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 296.2 |
Cas No. | 70-00-8 |
Formula | C10H11F3N2O5 |
Solubility | ≥14.45 mg/mL in DMSO; ≥17.03 mg/mL in EtOH with ultrasonic; ≥3.72 mg/mL in H2O with ultrasonic |
Chemical Name | 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(trifluoromethyl)pyrimidine-2,4-dione |
SDF | Download SDF |
Canonical SMILES | C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O |
Shipping Condition | Small Molecules with Blue Ice, Modified Nucleotides with Dry Ice. |
General tips | We do not recommend long-term storage for the solution, please use it up soon. |
Quality Control & MSDS
- View current batch: